WOBURN, Mass.--(BUSINESS WIRE)--BioTrove, Inc. today announced it will present data this week demonstrating compatibility of its RapidFire® Mass Spectrometry (RF-MS) system with Agilent Technologies Inc.’s (NYSE:A) Time-of-Flight (TOF) mass spectrometer system for high-throughput screening of protein inhibitors and examination of drug-drug interaction assays. Combining the two platforms, drug discovery researchers can now perform high-throughput drug-drug interaction and label-free kinase assays using whole protein substrates. These data are presented in two posters at the 57th American Society for Mass Spectrometry Conference on Mass Spectrometry in Philadelphia, Pennsylvania.
